← All news
Markets
Protagonist Therapeutics, Inc. (PTGX) Discusses FDA Approval of Mimrylo for Erythrocytosis in Polycythemia Vera - Slideshow
Covered by 1 outlet
All coverage · 2 articles
Seeking Alpha
·Aug 31, 19:54 UTC
Protagonist Therapeutics, Inc. (PTGX) Discusses FDA Approval of Mimrylo for Erythrocytosis in Polycythemia Vera Transcript
Seeking Alpha
·Aug 31, 15:01 UTC